Mini-monoka punctocanaliculoplasty manages canalicular stenosis

Article

Epiphora secondary to punctal and canalicular stenosis is successfully managed by mini-monoka punctocanaliculoplasty.

Epiphora secondary to punctal and canalicular stenosis is successfully managed by mini-monoka punctocanaliculoplasty, according to a study in the British Journal of Ophthalmology.

Dr R.N. Hussain et al., Department of Ophthalmology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK, performed a retrospective case note analysis on 123 eyes of 77 consecutive patients.

Of the eyes studied, 73% had punctal stenosis, 72% had canalicuar stenosis, 46% had both punctal stenosis and canalicuar stenosis, 20% had some severity of lid laxity and 29% had nasolacrimal duct stenosis.

After treatment, 82% of the eyes demonstrated a significant improvement in symptoms. The success rate was raised to 88% when structural comorbidity patients were excluded from the study.

It was discovered that mini-monoka punctocanaliculoplasty is an effective, safe, simple and fairly non-invasive treatment for epiphora secondary to punctal and/or canalicular stenosis.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.